A detailed history of Uni Super Management Pty LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Uni Super Management Pty LTD holds 6,932 shares of NBIX stock, worth $868,579. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,932
Previous 1,400 395.14%
Holding current value
$868,579
Previous $193 Million 99.51%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$130.86 - $143.19 $723,917 - $792,127
5,532 Added 395.14%
6,932 $954,000
Q1 2024

May 13, 2024

BUY
$130.4 - $143.74 $91,280 - $100,618
700 Added 100.0%
1,400 $193 Million
Q2 2023

Nov 13, 2023

SELL
$89.53 - $104.87 $9.21 Million - $10.8 Million
-102,893 Reduced 99.32%
700 $66 Million
Q2 2023

Aug 14, 2023

BUY
$89.53 - $104.87 $9.27 Million - $10.9 Million
103,593 New
103,593 $9.77 Billion

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Uni Super Management Pty LTD Portfolio

Follow Uni Super Management Pty LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uni Super Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uni Super Management Pty LTD with notifications on news.